Bone Biologics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 16, 2021 at 10:46 pm IST
Bone Biologics Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 231,881 compared to USD 132,709 a year ago. Net loss was USD 491,898 compared to USD 380,030 a year ago. For the half year, operating loss was USD 412,805 compared to USD 472,759 a year ago. Net loss was USD 923,645 compared to USD 976,930 a year ago.